この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Alejandro M.に依頼
Argentina
Clinical Research Associate with 3+ years experience / Research Scientist with 20+ years of experience
プロフィール概要
専門分野
サービス
職務経験
Biology / Molecular Biology Expert
Outlier
5月 2025 - 現在
Biology/Molecular Biology Expert - Freelance
Outlier
5月 2025 - 現在 ![]()
Medical Science Liaison / Clinical Research Associate
Oncoprecision
3月 2024 - 5月 2025
Medical Science Liaison /Clinical Research Associate
OncoPrecision
3月 2024 - 4月 2025 ![]()
Head of the Solid Tumor Project
Oncoprecision
3月 2022 - 2月 2024
Head of Solid Tumor Project
OncoPrecision
3月 2022 - 2月 2024 ![]()
Investigador Adjunto de CONICET/Associate Researcher
Centro de Investigaciones en Química Biológica de Córdoba
5月 2013 - 11月 2022 ![]()
Profesor Asistente/Assistant Professor
Universidad Nacional de Córdoba Facultad de Ciencias Químicas
7月 2003 - 9月 2022 ![]()
Senior Cell Biologist
OncoPrecision
4月 2021 - 2月 2022 ![]()
Senior Cell Biologist
Oncoprecision
4月 2021 - 2月 2022
学歴
PhD in Chemistry
Universidad Nacional de Córdoba
12月 2009 - 現在 ![]()
´Biologist
Universidad Nacional de Córdoba
3月 2002 - 現在 ![]()
認定資格
-
ICH Good Clinical Practice E6(R3)
The Global Health Network
https://globalhealthtrainingcentre.tghn.org/community/members/52469353-b858-44e9-805d-28e15ef86179/1月 2026 - 現在
-
Gestión de centros de investigación clínica farmacológica (Management of clinical pharmacological research centers)
FEFyM
https://fefym.org.ar/campus/aula/pdf/diploma.php?token=a702ee34cf393fd60088d1dbba246884e9998dbf10月 2025 - 現在
-
Diseño y Entrenamiento en buenas prácticas clínicas - Regulaciones y Pautas vigentes aplicables a estudios observacionales (Design and Training in good clinical practices)
FEFyM
10月 2024 - 現在
-
Monitoreo de estudios clínicos (Monitoring of clinical studies)
FEFyM
9月 2024 - 現在
-
Cambridge - First Certificate in English
University of Cambridge
12月 1993 - 現在
-
GOOD CLINICAL PRACTICE - Certificate of Completion
NIDA Clinical Trials Network
9月 2024 - 9月 2026
出版物
JOURNAL ARTICLE
Center for AI Safety, Scale AI, HLE Contributors Consortium (2026). A benchmark of expert-level academic questions to assess AI capabilities . Nature.
Tobares, R.A., Martino, R.A., Colque, C.A., Castillo Moro, G.L., Moyano, A.J., Albarracín Orio, A.G., Smania, A.M.(2025). Hypermutability bypasses genetic constraints in SCV phenotypic switching in Pseudomonas aeruginosa biofilms . Npj Biofilms and Microbiomes. 11. (1).
Colque, C.A., albarracín Orio, A.G., Tomatis, P.E., Dotta, G., Moreno, D.M., Hedemann, L.G., Hickman, R.A., Sommer, L.M., Feliziani, S., Moyano, A.J., et al.(2022). Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams . mBio. 13. (5).
Prezzavento, G.E., Mas, C.R., Achaval Rodríguez, J., Juárez Calvi, R.N., Piskulic, L., Angelini, J., Allasia, M.B., Smania, A.M., Moyano, A.J.(2021). Comparison of efficacy of Povidone-Iodine, Ethanol, and an aerosol formulation of silver sulfadiazine in controlling microbial burden on sutures from clean surgeries . Journal of Burn Care and Research. 42. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 975-980.
Siri, M., Herrera, M., Moyano, A.J., Celej, M.S.(2021). Influence of the macromolecular crowder alginate in the fibrillar organization of the functional amyloid FapC from Pseudomonas aeruginosa . Archives of Biochemistry and Biophysics. 713.
Moyano, A.J., Mas, C.R., Colque, C.A., Smania, A.M.(2020). Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine . Burns. 46. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 128-135.
Albarracín Orio, A.G., Petras, D., Tobares, R.A., Aksenov, A.A., Wang, M., Juncosa, F., Sayago, P., Moyano, A.J., Dorrestein, P.C., Smania, A.M.(2020). Fungal–bacterial interaction selects for quorum sensing mutants with increased production of natural antifungal compounds . Communications Biology. 3. (1).
Luján, A.M., Moyano, A.J., Martino, R.A., Feliziani, S., Urretavizcaya, M., Smania, A.M.(2019). ImuB and ImuC contribute to UV-induced mutagenesis as part of the SOS regulon in Pseudomonas aeruginosa . Environmental and Molecular Mutagenesis.
Moyano, A.J., Racca, A.C., Soria, G., Saka, H.A., Andreoli, V., Smania, A.M., Sola, C., Bocco, J.L.(2018). c-jun proto-oncoprotein plays a protective role in lung epithelial cells exposed to Staphylococcal α-toxin . Frontiers in Cellular and Infection Microbiology. 8. (MAY).
Moyano, A.J., Tobares, R.A., Rizzi, Y.S., Krapp, A.R., Mondotte, J.A., Bocco, J.L., Saleh, M.-C., Carrillo, N., Smania, A.M.(2014). A Long-Chain Flavodoxin Protects Pseudomonas aeruginosa from Oxidative Stress and Host Bacterial Clearance . PLoS Genetics. 10. (2).
Feliziani, S., Marvig, R.L., Luján, A.M., Moyano, A.J., Di Rienzo, J.A., Krogh Johansen, H., Molin, S., Smania, A.M.(2014). Coexistence and Within-Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long-term Cystic Fibrosis Infections . PLoS Genetics. 10. (10).
Moyano, A.J., Feliziani, S., Di Rienzo, J.A., Smania, A.M.(2013). Simple sequence repeats together with mismatch repair deficiency can bias mutagenic pathways in Pseudomonas aeruginosa during chronic lung infection . PLoS ONE. 8. (11).
Sola, C., Paganini, H., Egea, A.L., Moyano, A.J., Garnero, A., Kevric, I., Culasso, C., Vindel, A., Lopardo, H., Bocco, J.L.(2012). Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children . PLoS ONE. 7. (1).
Feliziani, S., Luján, A.M., Moyano, A.J., Sola, C., Bocco, J.L., Montanaro, P., Canigia, L.F., Argaraña, C.E., Smania, A.M.(2010). Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in pseudomonas aeruginosa from cystic fibrosis chronic airways infections . PLoS ONE. 5. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1-12.
Moyano, A.J., Smania, A.M.(2009). Simple sequence repeats and mucoid conversion: Biased muca mutagenesis in mismatch repair-deficient pseudomonas aeruginosa . PLoS ONE. 4. (12).
Moyano, A.J., Luján, A.M., Argaraña, C.E., Smania, A.M.(2007). MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa . Molecular Microbiology. 64. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 547-559.
Luján, A.M., Moyano, A.J., Segura, I., Argaraña, C.E., Smania, A.M.(2007). Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain . Microbiology. 153. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 225-237.
Alejandro José Moyano, Graciela María Daniele(2003). Nuevo registro de Psilocybe (Fungi, Basidiomycotina, Agaricales) en Argentina . Acta Botanica Mexicana. (64). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 25. Instituto de Ecologia, A.C.
OTHER
Long Phan, Alice Gatti, Ziwen Han, Nathaniel Li, Josephina Hu, Hugh Zhang, Chen Bo Calvin Zhang, Mohamed Shaaban, John Ling, Sean Shi, et al.(2025). Humanity's Last Exam . arXiv. arXiv
Colque, C.A., Tomatis, P.E., Albarracín Orio, A.G., Dotta, G., Moreno, D.M., Hedemann, L.G., Hickman, R.A., Sommer, L.M., Feliziani, S., Moyano, A.J., et al.(2021). Development of antibiotic resistance reveals diverse evolutionary pathways to face the complex and dynamic environment of a long-term treated patient . bioRxiv.
Albarracín Orio, A.G., Petras, D., Tobares, R.A., Aksenov, A.A., Wang, M., Juncosa, F., Sayago, P., Moyano, A.J., Dorrestein, P.C., Smania, A.M., et al.(2018). Fungal-bacterial interaction selects for quorum sensing mutants and a metabolic shift towards the production of natural antifungal compounds . bioRxiv.